Evidence map›Paper›PMID 36350146›Full record

ArticleInfection and immunity2022

A Minimal Replicon Enables Efficacious, Species-Specific Gene Deletion in Chlamydia and Extension of Gene Knockout Studies to the Animal Model of Infection Using Chlamydia muridarum.

Kenneth A Fields, Maria D Bodero, Kaylyn R Scanlon, Travis J Jewett, Katerina Wolf

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Generation of Chromosomal Deletions in Chlamydia trachomatis.Methods in molecular biology (Clifton, N.J.) · 2027
    Article
  2. Article
  3. Review
  4. Complete deletion of theInfection and immunity · 2025
    Article
  5. Article
  6. Journal of bacteriology · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Metabolism and physiology of pathogenic bacterial obligate intracellular parasites.Frontiers in cellular and infection microbiology · 2024
    Review
  11. Article
  12. Advances in genetic manipulation ofFrontiers in immunology · 2023
    Review
  13. Review
  14. Molecular pathogenesis ofFrontiers in cellular and infection microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kenneth A FieldsDepartment of Microbiology, Immunology & Molecular Genetics, University of Kentuckygrid.266539.d College of Medicine, Lexington, Kentucky, USA.ORCID 0000-0002-4703-6778
Maria D BoderoDepartment of Microbiology, Immunology & Molecular Genetics, University of Kentuckygrid.266539.d College of Medicine, Lexington, Kentucky, USA.
Kaylyn R ScanlonDivision of Immunity and Pathogenesis, Burnett School of Biomedical Sciences, College of Medicine, University of Central Floridagrid.170430.1, Orlando, Florida, USA.
Travis J JewettDivision of Immunity and Pathogenesis, Burnett School of Biomedical Sciences, College of Medicine, University of Central Floridagrid.170430.1, Orlando, Florida, USA.
Katerina WolfDepartment of Microbiology, Immunology & Molecular Genetics, University of Kentuckygrid.266539.d College of Medicine, Lexington, Kentucky, USA.ORCID 0000-0003-4469-1272
University of Kentucky · USUniversity of Central Florida · US

Funding

Type III exported effectors of Chlamydia trachomatisR01AI065530 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI FIELDS, KENNETH A · 2005 to 2021
$5.7M
Molecular Analysis of the Chlamydia trachomatis virulence factor TarpR01AI139242 · NIAID · UNIVERSITY OF CENTRAL FLORIDA · PI JEWETT, TRAVIS JAMES · 2019 to 2022
$2.3M
Chlamydia type III effectors affecting the host actin-based cytoskeletonR01AI175220 · NIAID · UNIVERSITY OF KENTUCKY · PI KENNETH A FIELDS · 2023 to 2026
$2.2M
Generation of deletion mutants in any chlamydial species: Quick and easy!R21AI166271 · NIAID · UNIVERSITY OF KENTUCKY · PI WOLF, KATERINA · 2021 to 2022
$421k
NIAID NIH HHS R01 AI065530NIAID NIH HHS R01 AI139242NIAID NIH HHS R01 AI175220NIAID NIH HHS R21 AI166271
6 · The paper itself

Abstract

The genus Chlamydia consists of diverse, obligate intracellular bacteria that infect various animals, including humans. Although chlamydial species share many aspects of the typical intracellular lifestyle, such as the biphasic developmental cycle and the preference for invasion of epithelial cells, each chlamydial strain also employs sophisticated species-specific strategies that contribute to an extraordinary diversity in organ and/or tissue tropism and disease manifestation. In order to discover and understand the mechanisms underlying how these pathogens infect particular hosts and cause specific diseases, it is imperative to develop a mutagenesis approach that would be applicable to every chlamydial species. We present functional evidence that the region between Chlamydia trachomatis and Chlamydia muridarum

Indexed as

Chlamydia InfectionsChlamydia muridarumAnimalsChlamydia trachomatisGene DeletionGene Knockout TechniquesHumansMiceModels, AnimalRepliconChlamydiamutagenesisplasmidTarp

Identifiers

PMID36350146
PMCPMC9753632
OpenAlexW4308639232

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.